| 1. Yu Q, Holloway HW, Utsuki T, Brossi A, Greig NH.. (1999) Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.. J Med Chem, 42 (10): (1855-1861). [PMID:10346939] [10.1021/jm980459s] |
| 2. Camps P, El Achab R, Morral J, Muñoz-Torrero D, Badia A, Baños JE, Vivas NM, Barril X, Orozco M, Luque FJ.. (2000) New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.. J Med Chem, 43 (24): (4657-4666). [PMID:11101357] [10.1021/jm000980y] |
| 3. Kim DK, Ryu DH, Lee JY, Lee N, Kim YW, Kim JS, Chang K, Im GJ, Kim TK, Choi WS.. (2001) Synthesis and biological evaluation of novel A-ring modified hexacyclic camptothecin analogues.. J Med Chem, 44 (10): (1594-1602). [PMID:11334569] [10.1021/jm0004751] |
| 4. Sterling J, Herzig Y, Goren T, Finkelstein N, Lerner D, Goldenberg W, Miskolczi I, Molnar S, Rantal F, Tamas T, Toth G, Zagyva A, Zekany A, Finberg J, Lavian G, Gross A, Friedman R, Razin M, Huang W, Krais B, Chorev M, Youdim MB, Weinstock M.. (2002) Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease.. J Med Chem, 45 (24): (5260-5279). [PMID:12431053] [10.1021/jm020120c] |
| 5. Tumiatti V, Rosini M, Bartolini M, Cavalli A, Marucci G, Andrisano V, Angeli P, Banzi R, Minarini A, Recanatini M, Melchiorre C.. (2003) Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine.. J Med Chem, 46 (6): (954-966). [PMID:12620072] [10.1021/jm021055+] |
| 6. Scott JS, Birch AM, Brocklehurst KJ, Broo A, Brown HS, Butlin RJ, Clarke DS, Davidsson O, Ertan A, Goldberg K et al.. (2012) Use of small-molecule crystal structures to address solubility in a novel series of G protein coupled receptor 119 agonists: optimization of a lead and in vivo evaluation.. J Med Chem, 55 (11): (5361-79). [PMID:22545772] [10.1021/op500134e] |
| 7. Luo W, Yu QS, Kulkarni SS, Parrish DA, Holloway HW, Tweedie D, Shafferman A, Lahiri DK, Brossi A, Greig NH. (2006) Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine.. J Med Chem, 49 (7): (2174-85). [PMID:16570913] [10.1021/op500134e] |
| 8. Theodoulou NH, Bamborough P, Bannister AJ, Becher I, Bit RA, Che KH, Chung CW, Dittmann A, Drewes G, Drewry DH et al.. (2016) Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.. J Med Chem, 59 (4): (1425-39). [PMID:25856009] [10.1021/op500134e] |
| 9. Yu QS, Holloway HW, Luo W, Lahiri DK, Brossi A, Greig NH. (2010) Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine.. Bioorg Med Chem, 18 (13): (4687-93). [PMID:20627738] [10.1021/op500134e] |
| 10. Migliore M, Habrant D, Sasso O, Albani C, Bertozzi SM, Armirotti A, Piomelli D, Scarpelli R. (2016) Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.. Eur J Med Chem, 109 (13): (216-37). [PMID:26774927] [10.1021/op500134e] |
| 11. Jiang XY, Chen TK, Zhou JT, He SY, Yang HY, Chen Y, Qu W, Feng F, Sun HP. (2018) Dual GSK-3β/AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer's Disease Drug Discovery.. ACS Med Chem Lett, 9 (3): (171-176). [PMID:29541355] [10.1021/op500134e] |
| 12. Sharma S, Hopkins CR. (2019) Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases.. J Med Chem, 62 (17): (7589-7602). [PMID:30943030] [10.1021/op500134e] |
| 13. Tang H, Zhu Y, Teumelsan N, Walsh SP, Shahripour A, Priest BT, Swensen AM, Felix JP, Brochu RM, Bailey T et al.. (2016) Discovery of MK-7145, an Oral Small Molecule ROMK Inhibitor for the Treatment of Hypertension and Heart Failure.. ACS Med Chem Lett, 7 (7): (697-701). [PMID:27437080] [10.1021/op500134e] |
| 14. Rochais C, Lecoutey C, Gaven F, Giannoni P, Hamidouche K, Hedou D, Dubost E, Genest D, Yahiaoui S, Freret T et al.. (2015) Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecopride.. J Med Chem, 58 (7): (3172-87). [PMID:25793650] [10.1021/op500134e] |
| 15. Lecoutey C, Hedou D, Freret T, Giannoni P, Gaven F, Since M, Bouet V, Ballandonne C, Corvaisier S, Malzert Fréon A et al.. (2014) Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment.. Proc Natl Acad Sci USA, 111 (36): (E3825-30). [PMID:25157130] [10.1021/op500134e] |
| 16. Cristóbal de Los Ríos,Javier Egea,José Marco-Contelles,Rafael León,Abdelouahid Samadi,Isabel Iriepa,Ignacio Moraleda,Enrique Gálvez,Antonio G García,Manuela G López,Mercedes Villarroya,Alejandro Romero. (2010-06-26) Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives.. Journal of medicinal chemistry, 53 ((14)): (5129-5143). [PMID:20575555] |
| 17. Natalia P Alza,Victoria Richmond,Carlos J Baier,Eleonora Freire,Ricardo Baggio,Ana Paula Murray. (2014-07-16) Synthesis and cholinesterase inhibition of cativic acid derivatives.. Bioorganic & medicinal chemistry, 22 ((15)): (3838-3849). [PMID:25017625] |
| 18. Ebdrup S, Sørensen LG, Olsen OH, Jacobsen P.. (2004) Synthesis and structure-activity relationship for a novel class of potent and selective carbamoyl-triazole based inhibitors of hormone sensitive lipase.. J Med Chem, 47 (2): (400-410). [PMID:14711311] [10.1021/jm031004s] |
| 19. Bolognesi ML, Bartolini M, Cavalli A, Andrisano V, Rosini M, Minarini A, Melchiorre C.. (2004) Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.. J Med Chem, 47 (24): (5945-5952). [PMID:15537349] [10.1021/jm049782n] |
| 20. Luo W, Yu QS, Zhan M, Parrish D, Deschamps JR, Kulkarni SS, Holloway HW, Alley GM, Lahiri DK, Brossi A, Greig NH.. (2005) Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.. J Med Chem, 48 (4): (986-994). [PMID:15715468] [10.1021/jm049309+] |
| 21. Marco-Contelles J, León R, de Los Ríos C, Guglietta A, Terencio J, López MG, García AG, Villarroya M.. (2006) Novel multipotent tacrine-dihydropyridine hybrids with improved acetylcholinesterase inhibitory and neuroprotective activities as potential drugs for the treatment of Alzheimer's disease.. J Med Chem, 49 (26): (7607-7610). [PMID:17181144] [10.1021/jm061047j] |
| 22. Schott Y, Decker M, Rommelspacher H, Lehmann J.. (2006) 6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors.. Bioorg Med Chem Lett, 16 (22): (5840-5843). [PMID:16945529] [10.1016/j.bmcl.2006.08.067] |
| 23. Bolognesi ML, Banzi R, Bartolini M, Cavalli A, Tarozzi A, Andrisano V, Minarini A, Rosini M, Tumiatti V, Bergamini C, Fato R, Lenaz G, Hrelia P, Cattaneo A, Recanatini M, Melchiorre C.. (2007) Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease.. J Med Chem, 50 (20): (4882-4897). [PMID:17850125] [10.1021/jm070559a] |
| 24. Piazzi L, Cavalli A, Colizzi F, Belluti F, Bartolini M, Mancini F, Recanatini M, Andrisano V, Rampa A.. (2008) Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds.. Bioorg Med Chem Lett, 18 (1): (423-426). [PMID:17998161] [10.1016/j.bmcl.2007.09.100] |
| 25. Xie Q, Wang H, Xia Z, Lu M, Zhang W, Wang X, Fu W, Tang Y, Sheng W, Li W, Zhou W, Zhu X, Qiu Z, Chen H.. (2008) Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation.. J Med Chem, 51 (7): (2027-2036). [PMID:18333606] [10.1021/jm070154q] |
| 26. Bembenek SD, Keith JM, Letavic MA, Apodaca R, Barbier AJ, Dvorak L, Aluisio L, Miller KL, Lovenberg TW, Carruthers NI.. (2008) Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling.. Bioorg Med Chem, 16 (6): (2968-2973). [PMID:18249544] [10.1016/j.bmc.2007.12.048] |
| 27. Rollinger JM, Schuster D, Baier E, Ellmerer EP, Langer T, Stuppner H.. (2006) Taspine: bioactivity-guided isolation and molecular ligand-target insight of a potent acetylcholinesterase inhibitor from Magnolia x soulangiana.. J Nat Prod, 69 (9): (1341-1346). [PMID:16989531] [10.1021/np060268p] |
| 28. Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP.. (2008) Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.. J Med Chem, 51 (14): (4150-4169). [PMID:18588282] [10.1021/jm701575k] |
| 29. Hicks LD, Hyatt JL, Stoddard S, Tsurkan L, Edwards CC, Wadkins RM, Potter PM.. (2009) Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) toxicity.. J Med Chem, 52 (12): (3742-3752). [PMID:19534556] [10.1021/jm9001296] |
| 30. Musilek K, Komloova M, Zavadova V, Holas O, Hrabinova M, Pohanka M, Dohnal V, Nachon F, Dolezal M, Dolezal M, Kuca K, Jung YS.. (2010) Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.. Bioorg Med Chem Lett, 20 (5): (1763-1766). [PMID:20138518] [10.1016/j.bmcl.2010.01.034] |
| 31. Kokel D, Bryan J, Laggner C, White R, Cheung CY, Mateus R, Healey D, Kim S, Werdich AA, Haggarty SJ, Macrae CA, Shoichet B, Peterson RT.. (2010) Rapid behavior-based identification of neuroactive small molecules in the zebrafish.. Nat Chem Biol, 6 (3): (231-237). [PMID:20081854] [10.1038/nchembio.307] |
| 32. Korabecny J, Musilek K, Holas O, Binder J, Zemek F, Marek J, Pohanka M, Opletalova V, Dohnal V, Kuca K.. (2010) Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.. Bioorg Med Chem Lett, 20 (20): (6093-6095). [PMID:20817518] [10.1016/j.bmcl.2010.08.044] |
| 33. Young BM, Hyatt JL, Bouck DC, Chen T, Hanumesh P, Price J, Boyd VA, Potter PM, Webb TR.. (2010) Structure-activity relationships of substituted 1-pyridyl-2-phenyl-1,2-ethanediones: potent, selective carboxylesterase inhibitors.. J Med Chem, 53 (24): (8709-8715). [PMID:21105730] [10.1021/jm101101q] |
| 34. Samadi A, Valderas C, de los Ríos C, Bastida A, Chioua M, González-Lafuente L, Colmena I, Gandía L, Romero A, Del Barrio L, Martín-de-Saavedra MD, López MG, Villarroya M, Marco-Contelles J.. (2011) Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles.. Bioorg Med Chem, 19 (1): (122-133). [PMID:21163662] [10.1016/j.bmc.2010.11.040] |
| 35. Musilek K, Komloova M, Holas O, Hrabinova M, Pohanka M, Dohnal V, Nachon F, Dolezal M, Dolezal M, Kuca K.. (2011) Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatment.. Eur J Med Chem, 46 (2): (811-818). [PMID:21236521] [10.1016/j.ejmech.2010.12.011] |
| 36. Komloova M, Musilek K, Horova A, Holas O, Dohnal V, Gunn-Moore F, Kuca K.. (2011) Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.. Bioorg Med Chem Lett, 21 (8): (2505-2509). [PMID:21397501] [10.1016/j.bmcl.2011.02.047] |
| 37. Mohamed T, Zhao X, Habib LK, Yang J, Rao PP.. (2011) Design, synthesis and structure-activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: dual activity as cholinesterase and Aβ-aggregation inhibitors.. Bioorg Med Chem, 19 (7): (2269-2281). [PMID:21429752] [10.1016/j.bmc.2011.02.030] |
| 38. Al-Rashid ZF, Hsung RP.. (2011) (+)-Arisugacin A--computational evidence of a dual binding site covalent inhibitor of acetylcholinesterase.. Bioorg Med Chem Lett, 21 (9): (2687-2691). [PMID:21216144] [10.1016/j.bmcl.2010.12.041] |
| 39. Conejo-García A, Pisani L, Núñez Mdel C, Catto M, Nicolotti O, Leonetti F, Campos JM, Gallo MA, Espinosa A, Carotti A.. (2011) Homodimeric bis-quaternary heterocyclic ammonium salts as potent acetyl- and butyrylcholinesterase inhibitors: a systematic investigation of the influence of linker and cationic heads over affinity and selectivity.. J Med Chem, 54 (8): (2627-2645). [PMID:21417225] [10.1021/jm101299d] |
| 40. Tasso B, Catto M, Nicolotti O, Novelli F, Tonelli M, Giangreco I, Pisani L, Sparatore A, Boido V, Carotti A, Sparatore F.. (2011) Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.. Eur J Med Chem, 46 (6): (2170-2184). [PMID:21459491] [10.1016/j.ejmech.2011.02.071] |
| 41. Parkinson EI, Jason Hatfield M, Tsurkan L, Hyatt JL, Edwards CC, Hicks LD, Yan B, Potter PM.. (2011) Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-diones.. Bioorg Med Chem, 19 (15): (4635-4643). [PMID:21733699] [10.1016/j.bmc.2011.06.012] |
| 42. Rizzo S, Bisi A, Bartolini M, Mancini F, Belluti F, Gobbi S, Andrisano V, Rampa A.. (2011) Multi-target strategy to address Alzheimer's disease: design, synthesis and biological evaluation of new tacrine-based dimers.. Eur J Med Chem, 46 (9): (4336-4343). [PMID:21798635] [10.1016/j.ejmech.2011.07.004] |
| 43. Huang W, Tang L, Shi Y, Huang S, Xu L, Sheng R, Wu P, Li J, Zhou N, Hu Y.. (2011) Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H₃R and BACE 1 inhibitory activities.. Bioorg Med Chem, 19 (23): (7158-7167). [PMID:22019465] [10.1016/j.bmc.2011.09.061] |
| 44. Bolea I, Juárez-Jiménez J, de Los Ríos C, Chioua M, Pouplana R, Luque FJ, Unzeta M, Marco-Contelles J, Samadi A.. (2011) Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.. J Med Chem, 54 (24): (8251-8270). [PMID:22023459] [10.1021/jm200853t] |
| 45. Bolognesi ML, Chiriano G, Bartolini M, Mancini F, Bottegoni G, Maestri V, Czvitkovich S, Windisch M, Cavalli A, Minarini A, Rosini M, Tumiatti V, Andrisano V, Melchiorre C.. (2011) Synthesis of monomeric derivatives to probe memoquin's bivalent interactions.. J Med Chem, 54 (24): (8299-8304). [PMID:22054058] [10.1021/jm200691d] |
| 46. Galdeano C, Viayna E, Sola I, Formosa X, Camps P, Badia A, Clos MV, Relat J, Ratia M, Bartolini M, Mancini F, Andrisano V, Salmona M, Minguillón C, González-Muñoz GC, Rodríguez-Franco MI, Bidon-Chanal A, Luque FJ, Muñoz-Torrero D.. (2012) Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases.. J Med Chem, 55 (2): (661-669). [PMID:22185619] [10.1021/jm200840c] |
| 47. Cho JK, Ryu YB, Curtis-Long MJ, Ryu HW, Yuk HJ, Kim DW, Kim HJ, Lee WS, Park KH.. (2012) Cholinestrase inhibitory effects of geranylated flavonoids from Paulownia tomentosa fruits.. Bioorg Med Chem, 20 (8): (2595-2602). [PMID:22445674] [10.1016/j.bmc.2012.02.044] |
| 48. Fernández-Bachiller MI, Pérez C, Monjas L, Rademann J, Rodríguez-Franco MI.. (2012) New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties.. J Med Chem, 55 (3): (1303-1317). [PMID:22243648] [10.1021/jm201460y] |
| 49. Samadi A, de los Ríos C, Bolea I, Chioua M, Iriepa I, Moraleda I, Bartolini M, Andrisano V, Gálvez E, Valderas C, Unzeta M, Marco-Contelles J.. (2012) Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.. Eur J Med Chem, 52 (251-262). [PMID:22503231] [10.1016/j.ejmech.2012.03.022] |
| 50. Rampa A, Bartolini M, Bisi A, Belluti F, Gobbi S, Andrisano V, Ligresti A, Di Marzo V.. (2012) The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease?. ACS Med Chem Lett, 3 (3): (182-186). [PMID:24900454] [10.1021/ml200313p] |
| 51. Mohamed T, Yeung JC, Vasefi MS, Beazely MA, Rao PP.. (2012) Development and evaluation of multifunctional agents for potential treatment of Alzheimer's disease: application to a pyrimidine-2,4-diamine template.. Bioorg Med Chem Lett, 22 (14): (4707-4712). [PMID:22704921] [10.1016/j.bmcl.2012.05.077] |
| 52. Hamulakova S, Janovec L, Hrabinova M, Kristian P, Kuca K, Banasova M, Imrich J.. (2012) Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease.. Eur J Med Chem, 55 (23-31). [PMID:22818849] [10.1016/j.ejmech.2012.06.051] |
| 53. Peng DY, Sun Q, Zhu XL, Lin HY, Chen Q, Yu NX, Yang WC, Yang GF.. (2012) Design, synthesis, and bioevaluation of benzamides: novel acetylcholinesterase inhibitors with multi-functions on butylcholinesterase, Aβ aggregation, and β-secretase.. Bioorg Med Chem, 20 (22): (6739-6750). [PMID:23041347] [10.1016/j.bmc.2012.09.016] |
| 54. Rizzo S, Tarozzi A, Bartolini M, Da Costa G, Bisi A, Gobbi S, Belluti F, Ligresti A, Allarà M, Monti JP, Andrisano V, Di Marzo V, Hrelia P, Rampa A.. (2012) 2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents.. Eur J Med Chem, 58 (519-532). [PMID:23164658] [10.1016/j.ejmech.2012.10.045] |
| 55. Montolio M, Gregori-Puigjané E, Pineda D, Mestres J, Navarro P.. (2012) Identification of small molecule inhibitors of amyloid β-induced neuronal apoptosis acting through the imidazoline I(2) receptor.. J Med Chem, 55 (22): (9838-9846). [PMID:23098038] [10.1021/jm301055g] |
| 56. Catto M, Pisani L, Leonetti F, Nicolotti O, Pesce P, Stefanachi A, Cellamare S, Carotti A.. (2013) Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase.. Bioorg Med Chem, 21 (1): (146-152). [PMID:23199476] [10.1016/j.bmc.2012.10.045] |
| 57. Mishra N, Sasmal D.. (2013) Additional acetyl cholinesterase inhibitory property of diaryl pyrazoline derivatives.. Bioorg Med Chem Lett, 23 (3): (702-705). [PMID:23276831] [10.1016/j.bmcl.2012.11.100] |
| 58. Hatfield MJ, Tsurkan LG, Hyatt JL, Edwards CC, Lemoff A, Jeffries C, Yan B, Potter PM.. (2013) Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen").. J Nat Prod, 76 (1): (36-44). [PMID:23286284] [10.1021/np300628a] |
| 59. Xing W, Fu Y, Shi Z, Lu D, Zhang H, Hu Y.. (2013) Discovery of novel 2,6-disubstituted pyridazinone derivatives as acetylcholinesterase inhibitors.. Eur J Med Chem, 63 (95-103). [PMID:23466605] [10.1016/j.ejmech.2013.01.056] |
| 60. Mohamed T, Osman W, Tin G, Rao PP.. (2013) Selective inhibition of human acetylcholinesterase by xanthine derivatives: in vitro inhibition and molecular modeling investigations.. Bioorg Med Chem Lett, 23 (15): (4336-4341). [PMID:23791077] [10.1016/j.bmcl.2013.05.092] |
| 61. Samadi A, de la Fuente Revenga M, Pérez C, Iriepa I, Moraleda I, Rodríguez-Franco MI, Marco-Contelles J.. (2013) Synthesis, pharmacological assessment, and molecular modeling of 6-chloro-pyridonepezils: new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease.. Eur J Med Chem, 67 (64-74). [PMID:23838422] [10.1016/j.ejmech.2013.06.021] |
| 62. Luo Z, Sheng J, Sun Y, Lu C, Yan J, Liu A, Luo HB, Huang L, Li X.. (2013) Synthesis and evaluation of multi-target-directed ligands against Alzheimer's disease based on the fusion of donepezil and ebselen.. J Med Chem, 56 (22): (9089-9099). [PMID:24160297] [10.1021/jm401047q] |
| 63. Sun Y, Chen J, Chen X, Huang L, Li X.. (2013) Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine-Homoisoflavonoid hybrids.. Bioorg Med Chem, 21 (23): (7406-7417). [PMID:24128814] [10.1016/j.bmc.2013.09.050] |
| 64. González-Naranjo P, Pérez-Macias N, Campillo NE, Pérez C, Arán VJ, Girón R, Sánchez-Robles E, Martín MI, Gómez-Cañas M, García-Arencibia M, Fernández-Ruiz J, Páez JA.. (2014) Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease.. Eur J Med Chem, 73 (56-72). [PMID:24378710] [10.1016/j.ejmech.2013.11.026] |
| 65. Belluti F, De Simone A, Tarozzi A, Bartolini M, Djemil A, Bisi A, Gobbi S, Montanari S, Cavalli A, Andrisano V, Bottegoni G, Rampa A.. (2014) Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease.. Eur J Med Chem, 78 (157-166). [PMID:24681980] [10.1016/j.ejmech.2014.03.042] |
| 66. Carreño Otero AL, Vargas Méndez LY, Duque L JE, Kouznetsov VV.. (2014) Design, synthesis, acetylcholinesterase inhibition and larvicidal activity of girgensohnine analogs on Aedes aegypti, vector of dengue fever.. Eur J Med Chem, 78 (392-400). [PMID:24704612] [10.1016/j.ejmech.2014.03.067] |
| 67. Viayna E, Sola I, Bartolini M, De Simone A, Tapia-Rojas C, Serrano FG, Sabaté R, Juárez-Jiménez J, Pérez B, Luque FJ, Andrisano V, Clos MV, Inestrosa NC, Muñoz-Torrero D.. (2014) Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents.. J Med Chem, 57 (6): (2549-2567). [PMID:24568372] [10.1021/jm401824w] |
| 68. Brus B, Košak U, Turk S, Pišlar A, Coquelle N, Kos J, Stojan J, Colletier JP, Gobec S.. (2014) Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.. J Med Chem, 57 (19): (8167-8179). [PMID:25226236] [10.1021/jm501195e] |
| 69. Lan JS, Xie SS, Li SY, Pan LF, Wang XB, Kong LY.. (2014) Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.. Bioorg Med Chem, 22 (21): (6089-6104). [PMID:25282654] [10.1016/j.bmc.2014.08.035] |
| 70. Tao L, Xie J, Wang Y, Wang S, Wu S, Wang Q, Ding H.. (2014) Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.. Bioorg Med Chem Lett, 24 (23): (5385-5389). [PMID:25453793] [10.1016/j.bmcl.2014.10.049] |
| 71. Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T.. (2014) Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.. Bioorg Med Chem Lett, 24 (14): (3189-3193). [PMID:24856064] [10.1016/j.bmcl.2014.04.085] |
| 72. Sandhu S, Bansal Y, Silakari O, Bansal G.. (2014) Coumarin hybrids as novel therapeutic agents.. Bioorg Med Chem, 22 (15): (3806-3814). [PMID:24934993] [10.1016/j.bmc.2014.05.032] |
| 73. Sun Q, Peng DY, Yang SG, Zhu XL, Yang WC, Yang GF.. (2014) Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase.. Bioorg Med Chem, 22 (17): (4784-4791). [PMID:25088549] [10.1016/j.bmc.2014.06.057] |
| 74. Liao S, Deng H, Huang S, Yang J, Wang S, Yin B, Zheng T, Zhang D, Liu J, Gao G, Ma J, Deng Z.. (2015) Design, synthesis and evaluation of novel 5,6,7-trimethoxyflavone-6-chlorotacrine hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.. Bioorg Med Chem Lett, 25 (7): (1541-1545). [PMID:25724825] [10.1016/j.bmcl.2015.02.015] |
| 75. Xie SS, Wang X, Jiang N, Yu W, Wang KD, Lan JS, Li ZR, Kong LY.. (2015) Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease.. Eur J Med Chem, 95 (153-165). [PMID:25812965] [10.1016/j.ejmech.2015.03.040] |
| 76. Farina R, Pisani L, Catto M, Nicolotti O, Gadaleta D, Denora N, Soto-Otero R, Mendez-Alvarez E, Passos CS, Muncipinto G, Altomare CD, Nurisso A, Carrupt PA, Carotti A.. (2015) Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases.. J Med Chem, 58 (14): (5561-5578). [PMID:26107513] [10.1021/acs.jmedchem.5b00599] |
| 77. Rampa A, Mancini F, De Simone A, Falchi F, Belluti F, Di Martino RM, Gobbi S, Andrisano V, Tarozzi A, Bartolini M, Cavalli A, Bisi A.. (2015) From AChE to BACE1 inhibitors: The role of the amine on the indanone scaffold.. Bioorg Med Chem Lett, 25 (14): (2804-2808). [PMID:26003339] [10.1016/j.bmcl.2015.05.002] |
| 78. Camerino E, Wong DM, Tong F, Körber F, Gross AD, Islam R, Viayna E, Mutunga JM, Li J, Totrov MM, Bloomquist JR, Carlier PR.. (2015) Difluoromethyl ketones: Potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase.. Bioorg Med Chem Lett, 25 (20): (4405-4411). [PMID:26386602] [10.1016/j.bmcl.2015.09.019] |
| 79. Luo XT, Wang CM, Liu Y, Huang ZG.. (2015) New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer's disease.. Eur J Med Chem, 103 (302-311). [PMID:26363866] [10.1016/j.ejmech.2015.08.052] |
| 80. Al-Rashid ZF, Hsung RP.. (2015) A computational view on the significance of E-ring in binding of (+)-arisugacin A to acetylcholinesterase.. Bioorg Med Chem Lett, 25 (21): (4848-4853). [PMID:26159481] [10.1016/j.bmcl.2015.06.047] |
| 81. Zha X, Lamba D, Zhang L, Lou Y, Xu C, Kang D, Chen L, Xu Y, Zhang L, De Simone A, Samez S, Pesaresi A, Stojan J, Lopez MG, Egea J, Andrisano V, Bartolini M.. (2016) Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography.. J Med Chem, 59 (1): (114-131). [PMID:26632651] [10.1021/acs.jmedchem.5b01119] |
| 82. Lemes LF, de Andrade Ramos G, de Oliveira AS, da Silva FM, de Castro Couto G, da Silva Boni M, Guimarães MJ, Souza IN, Bartolini M, Andrisano V, do Nascimento Nogueira PC, Silveira ER, Brand GD, Soukup O, Korábečný J, Romeiro NC, Castro NG, Bolognesi ML, Romeiro LA.. (2016) Cardanol-derived AChE inhibitors: Towards the development of dual binding derivatives for Alzheimer's disease.. Eur J Med Chem, 108 (687-700). [PMID:26735910] [10.1016/j.ejmech.2015.12.024] |
| 83. Xie SS, Lan JS, Wang X, Wang ZM, Jiang N, Li F, Wu JJ, Wang J, Kong LY.. (2016) Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer's disease.. Bioorg Med Chem, 24 (7): (1528-1539). [PMID:26917219] [10.1016/j.bmc.2016.02.023] |
| 84. Huard K, Gosset JR, Montgomery JI, Gilbert A, Hayward MM, Magee TV, Cabral S, Uccello DP, Bahnck K, Brown J, Purkal J, Gorgoglione M, Lanba A, Futatsugi K, Herr M, Genung NE, Aspnes G, Polivkova J, Garcia-Irizarry CN, Li Q, Canterbury D, Niosi M, Vera NB, Li Z, Khunte B, Siderewicz J, Rolph T, Erion DM.. (2016) Optimization of a Dicarboxylic Series for in Vivo Inhibition of Citrate Transport by the Solute Carrier 13 (SLC13) Family.. J Med Chem, 59 (3): (1165-1175). [PMID:26734723] [10.1021/acs.jmedchem.5b01752] |
| 85. Sawatzky E, Wehle S, Kling B, Wendrich J, Bringmann G, Sotriffer CA, Heilmann J, Decker M.. (2016) Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode.. J Med Chem, 59 (5): (2067-2082). [PMID:26886849] [10.1021/acs.jmedchem.5b01674] |
| 86. Li Y, Qiang X, Li Y, Yang X, Luo L, Xiao G, Cao Z, Tan Z, Deng Y.. (2016) Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.. Bioorg Med Chem Lett, 26 (8): (2035-2039). [PMID:26947607] [10.1016/j.bmcl.2016.02.079] |
| 87. Blanco MJ, Vetman T, Chandrasekhar S, Fisher MJ, Harvey A, Kuklish SL, Chambers M, Lin C, Mudra D, Oskins J, Wang XS, Yu XP, Warshawsky AM.. (2016) Identification and biological activity of 6-alkyl-substituted 3-methyl-pyridine-2-carbonyl amino dimethyl-benzoic acid EP4 antagonists.. Bioorg Med Chem Lett, 26 (9): (2303-2307). [PMID:27020304] [10.1016/j.bmcl.2016.03.041] |
| 88. Costanzo P, Cariati L, Desiderio D, Sgammato R, Lamberti A, Arcone R, Salerno R, Nardi M, Masullo M, Oliverio M.. (2016) Design, Synthesis, and Evaluation of Donepezil-Like Compounds as AChE and BACE-1 Inhibitors.. ACS Med Chem Lett, 7 (5): (470-475). [PMID:27190595] [10.1021/acsmedchemlett.5b00483] |
| 89. Wu MY, Esteban G, Brogi S, Shionoya M, Wang L, Campiani G, Unzeta M, Inokuchi T, Butini S, Marco-Contelles J.. (2016) Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation.. Eur J Med Chem, 121 (864-879). [PMID:26471320] [10.1016/j.ejmech.2015.10.001] |
| 90. Wang ZM, Cai P, Liu QH, Xu DQ, Yang XL, Wu JJ, Kong LY, Wang XB.. (2016) Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.. Eur J Med Chem, 123 (282-297). [PMID:27484514] [10.1016/j.ejmech.2016.07.052] |
| 91. Więckowska A, Kołaczkowski M, Bucki A, Godyń J, Marcinkowska M, Więckowski K, Zaręba P, Siwek A, Kazek G, Głuch-Lutwin M, Mierzejewski P, Bienkowski P, Sienkiewicz-Jarosz H, Knez D, Wichur T, Gobec S, Malawska B.. (2016) Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation.. Eur J Med Chem, 124 (63-81). [PMID:27560283] [10.1016/j.ejmech.2016.08.016] |
| 92. de Candia M, Zaetta G, Denora N, Tricarico D, Majellaro M, Cellamare S, Altomare CD.. (2017) New azepino[4,3-b]indole derivatives as nanomolar selective inhibitors of human butyrylcholinesterase showing protective effects against NMDA-induced neurotoxicity.. Eur J Med Chem, 125 (288-298). [PMID:27688184] [10.1016/j.ejmech.2016.09.037] |
| 93. Panek D, Więckowska A, Wichur T, Bajda M, Godyń J, Jończyk J, Mika K, Janockova J, Soukup O, Knez D, Korabecny J, Gobec S, Malawska B.. (2017) Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation.. Eur J Med Chem, 125 (676-695). [PMID:27721153] [10.1016/j.ejmech.2016.09.078] |
| 94. Cheeseman MD, Chessum NE, Rye CS, Pasqua AE, Tucker MJ, Wilding B, Evans LE, Lepri S, Richards M, Sharp SY, Ali S, Rowlands M, O'Fee L, Miah A, Hayes A, Henley AT, Powers M, Te Poele R, De Billy E, Pellegrino L, Raynaud F, Burke R, van Montfort RL, Eccles SA, Workman P, Jones K.. (2017) Discovery of a Chemical Probe Bisamide (CCT251236): An Orally Bioavailable Efficacious Pirin Ligand from a Heat Shock Transcription Factor 1 (HSF1) Phenotypic Screen.. J Med Chem, 60 (1): (180-201). [PMID:28004573] [10.1021/acs.jmedchem.6b01055] |
| 95. Dgachi Y, Sokolov O, Luzet V, Godyń J, Panek D, Bonet A, Martin H, Iriepa I, Moraleda I, García-Iriepa C, Janockova J, Richert L, Soukup O, Malawska B, Chabchoub F, Marco-Contelles J, Ismaili L.. (2017) Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy.. Eur J Med Chem, 126 (576-589). [PMID:27918993] [10.1016/j.ejmech.2016.11.050] |
| 96. Li Y, Qiang X, Luo L, Yang X, Xiao G, Liu Q, Ai J, Tan Z, Deng Y.. (2017) Aurone Mannich base derivatives as promising multifunctional agents with acetylcholinesterase inhibition, anti-β-amyloid aggragation and neuroprotective properties for the treatment of Alzheimer's disease.. Eur J Med Chem, 126 (762-775). [PMID:27951485] [10.1016/j.ejmech.2016.12.009] |
| 97. Wu J, Tian Y, Wang S, Pistolozzi M, Jin Y, Zhou T, Roy G, Xu L, Tan W.. (2017) Design, synthesis and biological evaluation of bambuterol analogues as novel inhibitors of butyrylcholinesterase.. Eur J Med Chem, 126 (61-71). [PMID:27744187] [10.1016/j.ejmech.2016.08.061] |
| 98. Sang Z, Pan W, Wang K, Ma Q, Yu L, Yang Y, Bai P, Leng C, Xu Q, Li X, Tan Z, Liu W.. (2017) Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.. Eur J Med Chem, 130 (379-392). [PMID:28279845] [10.1016/j.ejmech.2017.02.039] |
| 99. McEneny-King A, Osman W, Edginton AN, Rao PPN.. (2017) Cytochrome P450 binding studies of novel tacrine derivatives: Predicting the risk of hepatotoxicity.. Bioorg Med Chem Lett, 27 (11): (2443-2449). [PMID:28400237] [10.1016/j.bmcl.2017.04.006] |
| 100. Dolles D, Hoffmann M, Gunesch S, Marinelli O, Möller J, Santoni G, Chatonnet A, Lohse MJ, Wittmann HJ, Strasser A, Nabissi M, Maurice T, Decker M.. (2018) Structure-Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles.. J Med Chem, 61 (4): (1646-1663). [PMID:29400965] [10.1021/acs.jmedchem.7b01760] |
| 101. Košak U, Brus B, Knez D, Žakelj S, Trontelj J, Pišlar A, Šink R, Jukič M, Živin M, Podkowa A, Nachon F, Brazzolotto X, Stojan J, Kos J, Coquelle N, Sałat K, Colletier JP, Gobec S.. (2018) The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity.. J Med Chem, 61 (1): (119-139). [PMID:29227101] [10.1021/acs.jmedchem.7b01086] |
| 102. Lan JS, Zhang T, Liu Y, Yang J, Xie SS, Liu J, Miao ZY, Ding Y.. (2017) Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.. Eur J Med Chem, 133 (184-196). [PMID:28388521] [10.1016/j.ejmech.2017.02.045] |
| 103. Makhaeva GF, Lushchekina SV, Boltneva NP, Serebryakova OG, Rudakova EV, Ustyugov AA, Bachurin SO, Shchepochkin AV, Chupakhin ON, Charushin VN, Richardson RJ.. (2017) 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.. Bioorg Med Chem, 25 (21): (5981-5994). [PMID:28986116] [10.1016/j.bmc.2017.09.028] |
| 104. Sang Z, Wang K, Wang H, Yu L, Wang H, Ma Q, Ye M, Han X, Liu W.. (2017) Design, synthesis and biological evaluation of phthalimide-alkylamine derivatives as balanced multifunctional cholinesterase and monoamine oxidase-B inhibitors for the treatment of Alzheimer's disease.. Bioorg Med Chem Lett, 27 (22): (5053-5059). [PMID:29033232] [10.1016/j.bmcl.2017.09.055] |
| 105. Zhou LY, Zhu Y, Jiang YR, Zhao XJ, Guo D.. (2017) Design, synthesis and biological evaluation of dual acetylcholinesterase and phosphodiesterase 5A inhibitors in treatment for Alzheimer's disease.. Bioorg Med Chem Lett, 27 (17): (4180-4184). [PMID:28751142] [10.1016/j.bmcl.2017.07.013] |
| 106. Pandolfi F, De Vita D, Bortolami M, Coluccia A, Di Santo R, Costi R, Andrisano V, Alabiso F, Bergamini C, Fato R, Bartolini M, Scipione L.. (2017) New pyridine derivatives as inhibitors of acetylcholinesterase and amyloid aggregation.. Eur J Med Chem, 141 (197-210). [PMID:29031067] [10.1016/j.ejmech.2017.09.022] |
| 107. Bautista-Aguilera ÓM, Budni J, Mina F, Medeiros EB, Deuther-Conrad W, Entrena JM, Moraleda I, Iriepa I, López-Muñoz F, Marco-Contelles J.. (2018) Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile.. J Med Chem, 61 (15): (6937-6943). [PMID:29969030] [10.1021/acs.jmedchem.8b00848] |
| 108. Botić T, Defant A, Zanini P, Žužek MC, Frangež R, Janussen D, Kersken D, Knez Ž, Mancini I, Sepčić K.. (2017) Discorhabdin alkaloids from Antarctic Latrunculia spp. sponges as a new class of cholinesterase inhibitors.. Eur J Med Chem, 136 (294-304). [PMID:28505534] [10.1016/j.ejmech.2017.05.019] |
| 109. Jiang N, Huang Q, Liu J, Liang N, Li Q, Li Q, Xie SS.. (2018) Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease.. Eur J Med Chem, 146 (287-298). [PMID:29407958] [10.1016/j.ejmech.2018.01.055] |
| 110. Samaradivakara SP, Samarasekera R, Handunnetti SM, Weerasena OVDSJ, Al-Hamashi AA, Slama JT, Taylor WR, Alhadidi Q, Shah ZA, Perera L, Tillekeratne LMV.. (2018) A Bioactive Resveratrol Trimer from the Stem Bark of the Sri Lankan Endemic Plant Vateria copallifera.. J Nat Prod, 81 (8): (1693-1700). [PMID:30040425] [10.1021/acs.jnatprod.7b00892] |
| 111. Liu Z, Tian B, Chen H, Wang P, Brasier AR, Zhou J.. (2018) Discovery of potent and selective BRD4 inhibitors capable of blocking TLR3-induced acute airway inflammation.. Eur J Med Chem, 151 (450-461). [PMID:29649741] [10.1016/j.ejmech.2018.04.006] |
| 112. Ghobadian R, Mahdavi M, Nadri H, Moradi A, Edraki N, Akbarzadeh T, Sharifzadeh M, Bukhari SNA, Amini M.. (2018) Novel tetrahydrocarbazole benzyl pyridine hybrids as potent and selective butryl cholinesterase inhibitors with neuroprotective and β-secretase inhibition activities.. Eur J Med Chem, 155 (49-60). [PMID:29857276] [10.1016/j.ejmech.2018.05.031] |
| 113. Chioua M, Buzzi E, Moraleda I, Iriepa I, Maj M, Wnorowski A, Giovannini C, Tramarin A, Portali F, Ismaili L, López-Alvarado P, Bolognesi ML, Jóźwiak K, Menéndez JC, Marco-Contelles J, Bartolini M.. (2018) Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease.. Eur J Med Chem, 155 (839-846). [PMID:29958119] [10.1016/j.ejmech.2018.06.044] |
| 114. Zhao XJ, Gong DM, Jiang YR, Guo D, Zhu Y, Deng YC.. (2017) Multipotent AChE and BACE-1 inhibitors for the treatment of Alzheimer's disease: Design, synthesis and bio-analysis of 7-amino-1,4-dihydro-2H-isoquilin-3-one derivates.. Eur J Med Chem, 138 (738-747). [PMID:28728106] [10.1016/j.ejmech.2017.07.006] |
| 115. Lan JS, Ding Y, Liu Y, Kang P, Hou JW, Zhang XY, Xie SS, Zhang T.. (2017) Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease.. Eur J Med Chem, 139 (48-59). [PMID:28797883] [10.1016/j.ejmech.2017.07.055] |
| 116. Ma F, Du H.. (2017) Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.. Eur J Med Chem, 140 (118-127). [PMID:28923380] [10.1016/j.ejmech.2017.09.008] |
| 117. Li G, Hong G, Li X, Zhang Y, Xu Z, Mao L, Feng X, Liu T.. (2018) Synthesis and activity towards Alzheimer's disease in vitro: Tacrine, phenolic acid and ligustrazine hybrids.. Eur J Med Chem, 148 (238-254). [PMID:29466774] [10.1016/j.ejmech.2018.01.028] |
| 118. Hepnarova V, Korabecny J, Matouskova L, Jost P, Muckova L, Hrabinova M, Vykoukalova N, Kerhartova M, Kucera T, Dolezal R, Nepovimova E, Spilovska K, Mezeiova E, Pham NL, Jun D, Staud F, Kaping D, Kuca K, Soukup O.. (2018) The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disease.. Eur J Med Chem, 150 (292-306). [PMID:29533874] [10.1016/j.ejmech.2018.02.083] |
| 119. Gabr MT, Abdel-Raziq MS.. (2018) Structure-based design, synthesis, and evaluation of structurally rigid donepezil analogues as dual AChE and BACE-1 inhibitors.. Bioorg Med Chem Lett, 28 (17): (2910-2913). [PMID:30017317] [10.1016/j.bmcl.2018.07.019] |
| 120. Makhaeva GF, Boltneva NP, Lushchekina SV, Rudakova EV, Serebryakova OG, Kulikova LN, Beloglazkin AA, Borisov RS, Richardson RJ.. (2018) Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.. Bioorg Med Chem, 26 (16): (4716-4725). [PMID:30104121] [10.1016/j.bmc.2018.08.010] |
| 121. Liu QH, Wu JJ, Li F, Cai P, Yang XL, Kong LY, Wang XB.. (2017) Synthesis and pharmacological evaluation of multi-functional homoisoflavonoid derivatives as potent inhibitors of monoamine oxidase B and cholinesterase for the treatment of Alzheimer's disease.. Medchemcomm, 8 (7): (1459-1467). [PMID:30108857] [10.1039/C7MD00199A] |
| 122. Wu G, Gao Y, Kang D, Huang B, Huo Z, Liu H, Poongavanam V, Zhan P, Liu X.. (2018) Design, synthesis and biological evaluation of tacrine-1,2,3-triazole derivatives as potent cholinesterase inhibitors.. Medchemcomm, 9 (1): (149-159). [PMID:30108908] [10.1039/C7MD00457E] |
| 123. Hatfield MJ, Binder RJ, Gannon R, Fratt EM, Bowling J, Potter PM.. (2018) Potent, Irreversible Inhibition of Human Carboxylesterases by Tanshinone Anhydrides Isolated from Salvia miltiorrhiza ("Danshen").. J Nat Prod, 81 (11): (2410-2418). [PMID:30351923] [10.1021/acs.jnatprod.8b00378] |
| 124. Estrada Valencia M, Herrera-Arozamena C, de Andrés L, Pérez C, Morales-García JA, Pérez-Castillo A, Ramos E, Romero A, Viña D, Yáñez M, Laurini E, Pricl S, Rodríguez-Franco MI.. (2018) Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease.. Eur J Med Chem, 156 (534-553). [PMID:30025348] [10.1016/j.ejmech.2018.07.026] |
| 125. Cai P, Fang SQ, Yang HL, Yang XL, Liu QH, Kong LY, Wang XB.. (2018) Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.. Eur J Med Chem, 157 (161-176). [PMID:30096650] [10.1016/j.ejmech.2018.08.005] |
| 126. Pérez-Areales FJ, Turcu AL, Barniol-Xicota M, Pont C, Pivetta D, Espargaró A, Bartolini M, De Simone A, Andrisano V, Pérez B, Sabate R, Sureda FX, Vázquez S, Muñoz-Torrero D.. (2019) A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors.. Eur J Med Chem, 180 (613-626). [PMID:31351393] [10.1016/j.ejmech.2019.07.051] |
| 127. Bai P, Wang K, Zhang P, Shi J, Cheng X, Zhang Q, Zheng C, Cheng Y, Yang J, Lu X, Sang Z.. (2019) Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.. Eur J Med Chem, 183 (111737-111737). [PMID:31581002] [10.1016/j.ejmech.2019.111737] |
| 128. Tu Y, Wu C, Kang Y, Li Q, Zhu C, Li Y.. (2019) Bioactivity-guided identification of flavonoids with cholinesterase and β-amyloid peptide aggregation inhibitory effects from the seeds of Millettia pachycarpa.. Bioorg Med Chem Lett, 29 (10): (1194-1198). [PMID:30910460] [10.1016/j.bmcl.2019.03.024] |
| 129. Hoffmann M, Stiller C, Endres E, Scheiner M, Gunesch S, Sotriffer C, Maurice T, Decker M.. (2019) Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer's Disease Mouse Model.. J Med Chem, 62 (20): (9116-9140). [PMID:31609115] [10.1021/acs.jmedchem.9b01012] |
| 130. Pisani L, Iacobazzi RM, Catto M, Rullo M, Farina R, Denora N, Cellamare S, Altomare CD.. (2019) Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors.. Eur J Med Chem, 161 (292-309). [PMID:30366255] [10.1016/j.ejmech.2018.10.016] |
| 131. Hostalkova A, Marikova J, Opletal L, Korabecny J, Hulcova D, Kunes J, Novakova L, Perez DI, Jun D, Kucera T, Andrisano V, Siatka T, Cahlikova L.. (2019) Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease.. J Nat Prod, 82 (2): (239-248). [PMID:30701972] [10.1021/acs.jnatprod.8b00592] |
| 132. Unsal-Tan O, Tüylü Küçükkılınç T, Ayazgök B, Balkan A, Ozadali-Sari K.. (2019) Synthesis, molecular docking, and biological evaluation of novel 2-pyrazoline derivatives as multifunctional agents for the treatment of Alzheimer's disease.. Medchemcomm, 10 (6): (1018-1026). [PMID:31304000] [10.1039/C9MD00030E] |
| 133. AlFadly ED, Elzahhar PA, Tramarin A, Elkazaz S, Shaltout H, Abu-Serie MM, Janockova J, Soukup O, Ghareeb DA, El-Yazbi AF, Rafeh RW, Bakkar NZ, Kobeissy F, Iriepa I, Moraleda I, Saudi MNS, Bartolini M, Belal ASF.. (2019) Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase.. Eur J Med Chem, 167 (161-186). [PMID:30771604] [10.1016/j.ejmech.2019.02.012] |
| 134. Fang Y, Zhou H, Gu Q, Xu J.. (2019) Synthesis and evaluation of tetrahydroisoquinoline-benzimidazole hybrids as multifunctional agents for the treatment of Alzheimer's disease.. Eur J Med Chem, 167 (133-145). [PMID:30771601] [10.1016/j.ejmech.2019.02.008] |
| 135. Srivastava P, Tripathi PN, Sharma P, Shrivastava SK.. (2019) Design, synthesis, and evaluation of novel N-(4-phenoxybenzyl)aniline derivatives targeting acetylcholinesterase, β-amyloid aggregation and oxidative stress to treat Alzheimer's disease.. Bioorg Med Chem, 27 (16): (3650-3662). [PMID:31288978] [10.1016/j.bmc.2019.07.001] |
| 136. Zhang P, Xu S, Zhu Z, Xu J.. (2019) Multi-target design strategies for the improved treatment of Alzheimer's disease.. Eur J Med Chem, 176 (228-247). [PMID:31103902] [10.1016/j.ejmech.2019.05.020] |
| 137. Tzvetkov NT, Stammler HG, Georgieva MG, Russo D, Faraone I, Balacheva AA, Hristova S, Atanasov AG, Milella L, Antonov L, Gastreich M.. (2019) Carboxamides vs. methanimines: Crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors.. Eur J Med Chem, 179 (404-422). [PMID:31265934] [10.1016/j.ejmech.2019.06.041] |
| 138. Scheiner M, Dolles D, Gunesch S, Hoffmann M, Nabissi M, Marinelli O, Naldi M, Bartolini M, Petralla S, Poeta E, Monti B, Falkeis C, Vieth M, Hübner H, Gmeiner P, Maitra R, Maurice T, Decker M.. (2019) Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo.. J Med Chem, 62 (20): (9078-9102). [PMID:31609608] [10.1021/acs.jmedchem.9b00623] |
| 139. Lanthier C, Payan H, Liparulo I, Hatat B, Lecoutey C, Since M, Davis A, Bergamini C, Claeysen S, Dallemagne P, Bolognesi ML, Rochais C.. (2019) Novel multi target-directed ligands targeting 5-HT4 receptors with in cellulo antioxidant properties as promising leads in Alzheimer's disease.. Eur J Med Chem, 182 (111596-111596). [PMID:31419776] [10.1016/j.ejmech.2019.111596] |
| 140. Amato G, Manke A, Wiethe R, Vasukuttan V, Snyder R, Yueh YL, Decker A, Runyon S, Maitra R.. (2019) Functionalized 6-(Piperidin-1-yl)-8,9-Diphenyl Purines as Peripherally Restricted Inverse Agonists of the CB1 Receptor.. J Med Chem, 62 (13): (6330-6345). [PMID:31185168] [10.1021/acs.jmedchem.9b00727] |
| 141. Bajda M, Łażewska D, Godyń J, Zaręba P, Kuder K, Hagenow S, Łątka K, Stawarska E, Stark H, Kieć-Kononowicz K, Malawska B.. (2020) Search for new multi-target compounds against Alzheimer's disease among histamine H3 receptor ligands.. Eur J Med Chem, 185 (111785-111785). [PMID:31669851] [10.1016/j.ejmech.2019.111785] |
| 142. Oukoloff K, Coquelle N, Bartolini M, Naldi M, Le Guevel R, Bach S, Josselin B, Ruchaud S, Catto M, Pisani L, Denora N, Iacobazzi RM, Silman I, Sussman JL, Buron F, Colletier JP, Jean L, Routier S, Renard PY.. (2019) Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3.. Eur J Med Chem, 168 (58-77). [PMID:30798053] [10.1016/j.ejmech.2018.12.063] |
| 143. Chalupova K, Korabecny J, Bartolini M, Monti B, Lamba D, Caliandro R, Pesaresi A, Brazzolotto X, Gastellier AJ, Nachon F, Pejchal J, Jarosova M, Hepnarova V, Jun D, Hrabinova M, Dolezal R, Zdarova Karasova J, Mzik M, Kristofikova Z, Misik J, Muckova L, Jost P, Soukup O, Benkova M, Setnicka V, Habartova L, Chvojkova M, Kleteckova L, Vales K, Mezeiova E, Uliassi E, Valis M, Nepovimova E, Bolognesi ML, Kuca K.. (2019) Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease.. Eur J Med Chem, 168 (491-514). [PMID:30851693] [10.1016/j.ejmech.2019.02.021] |
| 144. Purgatorio R, de Candia M, Catto M, Carrieri A, Pisani L, De Palma A, Toma M, Ivanova OA, Voskressensky LG, Altomare CD.. (2019) Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.. Eur J Med Chem, 177 (414-424). [PMID:31158754] [10.1016/j.ejmech.2019.05.062] |
| 145. González-Naranjo P, Pérez-Macias N, Pérez C, Roca C, Vaca G, Girón R, Sánchez-Robles E, Martín-Fontelles MI, de Ceballos ML, Martin-Requero A, Campillo NE, Páez JA.. (2019) Indazolylketones as new multitarget cannabinoid drugs.. Eur J Med Chem, 166 (90-107). [PMID:30685536] [10.1016/j.ejmech.2019.01.030] |
| 146. Williams A, Zhou S, Zhan CG.. (2019) Discovery of potent and selective butyrylcholinesterase inhibitors through the use of pharmacophore-based screening.. Bioorg Med Chem Lett, 29 (24): (126754-126754). [PMID:31708262] [10.1016/j.bmcl.2019.126754] |
| 147. Matralis AN, Malik A, Penzo M, Moreno I, Almela MJ, Camino I, Crespo B, Saadeddin A, Ghidelli-Disse S, Rueda L, Calderon F, Osborne SA, Drewes G, Böesche M, Fernández-Álvaro E, Martin Hernando JI, Baker DA.. (2019) Development of Chemical Entities Endowed with Potent Fast-Killing Properties against Plasmodium falciparum Malaria Parasites.. J Med Chem, 62 (20): (9217-9235). [PMID:31566384] [10.1021/acs.jmedchem.9b01099] |
| 148. Dighe SN, Deora GS, De la Mora E, Nachon F, Chan S, Parat MO, Brazzolotto X, Ross BP.. (2016) Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening.. J Med Chem, 59 (16): (7683-7689). [PMID:27405689] [10.1021/acs.jmedchem.6b00356] |
| 149. Sharma P, Tripathi A, Tripathi PN, Prajapati SK, Seth A, Tripathi MK, Srivastava P, Tiwari V, Krishnamurthy S, Shrivastava SK.. (2019) Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease.. Eur J Med Chem, 167 (510-524). [PMID:30784883] [10.1016/j.ejmech.2019.02.030] |
| 150. Shidore M, Machhi J, Shingala K, Murumkar P, Sharma MK, Agrawal N, Tripathi A, Parikh Z, Pillai P, Yadav MR.. (2016) Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer's Agents: Synthesis and Biological Evaluation.. J Med Chem, 59 (12): (5823-5846). [PMID:27253679] [10.1021/acs.jmedchem.6b00426] |
| 151. de Los Ríos C, Marco-Contelles J.. (2019) Tacrines for Alzheimer's disease therapy. III. The PyridoTacrines.. Eur J Med Chem, 166 (381-389). [PMID:30739821] [10.1016/j.ejmech.2019.02.005] |
| 152. Catto M, Pisani L, de la Mora E, Belviso BD, Mangiatordi GF, Pinto A, Palma A, Denora N, Caliandro R, Colletier JP, Silman I, Nicolotti O, Altomare CD.. (2020) Chiral Separation, X-ray Structure, and Biological Evaluation of a Potent and Reversible Dual Binding Site AChE Inhibitor.. ACS Med Chem Lett, 11 (5): (869-876). [PMID:32435398] [10.1021/acsmedchemlett.9b00656] |
| 153. do Carmo Carreiras M, Ismaili L, Marco-Contelles J.. (2020) Propargylamine-derived multi-target directed ligands for Alzheimer's disease therapy.. Bioorg Med Chem Lett, 30 (3): (126880-126880). [PMID:31864798] [10.1016/j.bmcl.2019.126880] |
| 154. Wu J, Pistolozzi M, Liu S, Tan W.. (2020) Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase.. Bioorg Med Chem, 28 (5): (115324-115324). [PMID:32008882] [10.1016/j.bmc.2020.115324] |
| 155. Tripathi A,Choubey PK,Sharma P,Seth A,Tripathi PN,Tripathi MK,Prajapati SK,Krishnamurthy S,Shrivastava SK. (2019) Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease.. Eur J Med Chem, 183 (111707-111707). [PMID:31561043] [10.1016/j.ejmech.2019.111707] |
| 156. Noshita T,Fujita K,Koga T,Ouchi H,Tai A. (2021) Synthesis and biological activity of (±)-7,3',4'-trihydroxyhomoisoflavan and its analogs.. Bioorg Med Chem Lett, 31 (127674-127674). [PMID:33161123] [10.1016/j.bmcl.2020.127674] |
| 157. Tseng HJ,Lin MH,Shiao YJ,Yang YC,Chu JC,Chen CY,Chen YY,Lin TE,Su CJ,Pan SL,Chen LC,Wang CY,Hsu KC,Huang WJ. (2020) Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer's disease.. Eur J Med Chem, 192 (112193-112193). [PMID:32151835] [10.1016/j.ejmech.2020.112193] |
| 158. Sang Z,Wang K,Bai P,Wu A,Shi J,Liu W,Zhu G,Wang Y,Lan Y,Chen Z,Zhao Y,Qiao Z,Wang C,Tan Z. (2020) Design, synthesis and biological evaluation of novel O-carbamoyl ferulamide derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease.. Eur J Med Chem, 194 (112265-112265). [PMID:32240904] [10.1016/j.ejmech.2020.112265] |
| 159. Tripathi PN,Srivastava P,Sharma P,Seth A,Shrivastava SK. (2019) Design and development of novel N-(pyrimidin-2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions.. Bioorg Med Chem, 27 (7): (1327-1340). [PMID:30795991] [10.1016/j.bmc.2019.02.031] |
| 160. Choubey PK,Tripathi A,Sharma P,Shrivastava SK. (2020) Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer's disease.. Bioorg Med Chem, 28 (22): (115721-115721). [PMID:33007563] [10.1016/j.bmc.2020.115721] |
| 161. Sobolova K,Hrabinova M,Hepnarova V,Kucera T,Kobrlova T,Benkova M,Janockova J,Dolezal R,Prchal L,Benek O,Mezeiova E,Jun D,Soukup O,Korabecny J. (2020) Discovery of novel berberine derivatives with balanced cholinesterase and prolyl oligopeptidase inhibition profile.. Eur J Med Chem, 203 (112593-112593). [PMID:32688201] [10.1016/j.ejmech.2020.112593] |
| 162. Łażewska D,Bajda M,Kaleta M,Zaręba P,Doroz-Płonka A,Siwek A,Alachkar A,Mogilski S,Saad A,Kuder K,Olejarz-Maciej A,Godyń J,Stary D,Sudoł S,Więcek M,Latacz G,Walczak M,Handzlik J,Sadek B,Malawska B,Kieć-Kononowicz K. (2020) Rational design of new multitarget histamine H receptor ligands as potential candidates for treatment of Alzheimer's disease.. Eur J Med Chem, 207 (112743-112743). [PMID:32882609] [10.1016/j.ejmech.2020.112743] |
| 163. Meden A,Knez D,Malikowska-Racia N,Brazzolotto X,Nachon F,Svete J,Sałat K,Grošelj U,Gobec S. (2020) Structure-activity relationship study of tryptophan-based butyrylcholinesterase inhibitors.. Eur J Med Chem, 208 (112766-112766). [PMID:32919297] [10.1016/j.ejmech.2020.112766] |
| 164. Abdullaha M,Nuthakki VK,Bharate SB. (2020) Discovery of methoxy-naphthyl linked N-(1-benzylpiperidine) benzamide as a blood-brain permeable dual inhibitor of acetylcholinesterase and butyrylcholinesterase.. Eur J Med Chem, 207 (112761-112761). [PMID:32942070] [10.1016/j.ejmech.2020.112761] |
| 165. Jiang X,Zhou J,Wang Y,Chen L,Duan Y,Huang J,Liu C,Chen Y,Liu W,Sun H,Feng F,Qu W. (2020) Rational design and biological evaluation of a new class of thiazolopyridyl tetrahydroacridines as cholinesterase and GSK-3 dual inhibitors for Alzheimer's disease.. Eur J Med Chem, 207 (112751-112751). [PMID:32950908] [10.1016/j.ejmech.2020.112751] |
| 166. Erdogan M,Kilic B,Sagkan RI,Aksakal F,Ercetin T,Gulcan HO,Dogruer DS. (2021) Design, synthesis and biological evaluation of new benzoxazolone/benzothiazolone derivatives as multi-target agents against Alzheimer's disease.. Eur J Med Chem, 212 (113124-113124). [PMID:33395623] [10.1016/j.ejmech.2020.113124] |
| 167. Cao Z,Song Q,Yu G,Liu Z,Cong S,Tan Z,Deng Y. (2021) Novel 3-benzylidene/benzylphthalide Mannich base derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.. Bioorg Med Chem, 35 (116074-116074). [PMID:33640707] [10.1016/j.bmc.2021.116074] |
| 168. Pérez-Areales FJ,Garrido M,Aso E,Bartolini M,De Simone A,Espargaró A,Ginex T,Sabate R,Pérez B,Andrisano V,Puigoriol-Illamola D,Pallàs M,Luque FJ,Loza MI,Brea J,Ferrer I,Ciruela F,Messeguer A,Muñoz-Torrero D. (2020) Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6.. J Med Chem, 63 (17): (9360-9390). [PMID:32706255] [10.1021/acs.jmedchem.0c00528] |
| 169. Toublet FX,Lalut J,Hatat B,Lecoutey C,Davis A,Since M,Corvaisier S,Freret T,Sopková-de Oliveira Santos J,Claeysen S,Boulouard M,Dallemagne P,Rochais C. (2021) Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT receptor antagonist with therapeutic interest in Alzheimer's disease.. Eur J Med Chem, 210 (113059-113059). [PMID:33310288] [10.1016/j.ejmech.2020.113059] |
| 170. Singh YP,Tej GNVC,Pandey A,Priya K,Pandey P,Shankar G,Nayak PK,Rai G,Chittiboyina AG,Doerksen RJ,Vishwakarma S,Modi G. (2020) Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer's disease.. Eur J Med Chem, 198 (112257-112257). [PMID:32375073] [10.1016/j.ejmech.2020.112257] |
| 171. Košak U,Strašek N,Knez D,Jukič M,Žakelj S,Zahirović A,Pišlar A,Brazzolotto X,Nachon F,Kos J,Gobec S. (2020) N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.. Eur J Med Chem, 197 (112282-112282). [PMID:32380361] [10.1016/j.ejmech.2020.112282] |
| 172. Rodríguez-Lavado J,Gallardo-Garrido C,Mallea M,Bustos V,Osorio R,Hödar-Salazar M,Chung H,Araya-Maturana R,Lorca M,Pessoa-Mahana CD,Mella-Raipán J,Saitz C,Jaque P,Reyes-Parada M,Iturriaga-Vásquez P,Pessoa-Mahana H. (2020) Synthesis, in vitro evaluation and molecular docking of a new class of indolylpropyl benzamidopiperazines as dual AChE and SERT ligands for Alzheimer's disease.. Eur J Med Chem, 198 (112368-112368). [PMID:32388114] [10.1016/j.ejmech.2020.112368] |
| 173. Santi MD,Arredondo F,Carvalho D,Echeverry C,Prunell G,Peralta MA,Cabrera JL,Ortega MG,Savio E,Abin-Carriquiry JA. (2020) Neuroprotective effects of prenylated flavanones isolated from Dalea species, in vitro and in silico studies.. Eur J Med Chem, 206 (112718-112718). [PMID:32861919] [10.1016/j.ejmech.2020.112718] |
| 174. Sang Z, Song Q, Cao Z, Deng Y, Tan Z, Zhang L.. (2021) Design, synthesis and evaluation of novel dimethylamino chalcone-O-alkylamines derivatives as potential multifunctional agents against Alzheimer's disease.. Eur J Med Chem, 216 (113310-113310). [PMID:33667847] [10.1016/j.ejmech.2021.113310] |
| 175. Shafferman, A A and 9 more authors.. (1992) Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic activity and in polypeptide folding.. The Journal of biological chemistry, (5): [PMID:1517212] |
| 176. Velan, B B and 9 more authors.. (1991) The effect of elimination of intersubunit disulfide bonds on the activity, assembly, and secretion of recombinant human acetylcholinesterase. Expression of acetylcholinesterase Cys-580----Ala mutant.. The Journal of biological chemistry, (15): [PMID:1748670] |
| 177. Soreq, H H and 9 more authors.. (1990) Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure.. Proceedings of the National Academy of Sciences of the United States of America, [PMID:2263619] |
| 178. Chhajlani, V V, Derr, D D, Earles, B B, Schmell, E E and August, T T.. (1989) Purification and partial amino acid sequence analysis of human erythrocyte acetylcholinesterase.. FEBS letters, (24): [PMID:2714437] |
| 179. Karpel, R R and 8 more authors.. (1994) Expression of three alternative acetylcholinesterase messenger RNAs in human tumor cell lines of different tissue origins.. Experimental cell research, [PMID:8299725] |
| 180. Bartels, C F CF, Zelinski, T T and Lockridge, O O.. (1993) Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism.. American journal of human genetics, [PMID:8488842] |
| 181. Felder, C E CE, Botti, S A SA, Lifson, S S, Silman, I I and Sussman, J L JL.. (1997) External and internal electrostatic potentials of cholinesterase models.. Journal of molecular graphics & modelling, [PMID:9640563] |
| 182. Kryger, G G, Silman, I I and Sussman, J L JL.. (1999) Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs.. Structure (London, England : 1993), (15): [PMID:10368299] |
| 183. Kryger, G G and 11 more authors.. (2000) Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II.. Acta crystallographica. Section D, Biological crystallography, [PMID:11053835] |
| 184. Wilson, M D MD and 11 more authors.. (2001) Comparative analysis of the gene-dense ACHE/TFR2 region on human chromosome 7q22 with the orthologous region on mouse chromosome 5.. Nucleic acids research, (15): [PMID:11239002] |
| 185. Chen, X X, Ji, Z L ZL and Chen, Y Z YZ.. (2002) TTD: Therapeutic Target Database.. Nucleic acids research, (1): [PMID:11752352] |
| 186. Yang, Lei L, He, Heng-Yi HY and Zhang, Xue-Jun XJ.. (2002) Increased expression of intranuclear AChE involved in apoptosis of SK-N-SH cells.. Neuroscience research, [PMID:11985878] |
| 187. and Lilienfeld, Sean S.. (2002) Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease.. CNS drug reviews, [PMID:12177686] |
| 188. Bencharit, Sompop S and 6 more authors.. (2003) Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibition.. Chemistry & biology, [PMID:12725862] |
| 189. Hillier, Ladeana W LW and 106 more authors.. (2003) The DNA sequence of human chromosome 7.. Nature, (10): [PMID:12853948] |
| 190. Bolognesi, Maria Laura ML and 7 more authors.. (2003) Design, synthesis and biological evaluation of ambenonium derivatives as AChE inhibitors.. Farmaco (Societa chimica italiana : 1989), [PMID:13679187] |
| 191. Dvir, Hay H and 8 more authors.. (2004) The synaptic acetylcholinesterase tetramer assembles around a polyproline II helix.. The EMBO journal, (10): [PMID:15526038] |
| 192. Durcan, Niamh N and 9 more authors.. (2006) Eosinophil-mediated cholinergic nerve remodeling.. American journal of respiratory cell and molecular biology, [PMID:16456188] |
| 193. Ahmed, Mushtaq M and 7 more authors.. (2006) Inhibition of two different cholinesterases by tacrine.. Chemico-biological interactions, (25): [PMID:16860785] |
| 194. Onor, Maria Luisa; Trevisiol, Marianna and Aguglia, Eugenio.. (2007) Rivastigmine in the treatment of Alzheimer's disease: an update.. Clinical interventions in aging, [PMID:18044073] |
| 195. Ghadimi, Saied S, Valmoozi, Ali Asghar Ebrahimi AA, Pourayoubi, Mehrdad M and Samani, Keyvan Asad KA.. (2008) Structure-activity study of phosphoramido acid esters as acetylcholinesterase inhibitors.. Journal of enzyme inhibition and medicinal chemistry, [PMID:18666002] |
| 196. Gholivand, Khodayar K, Abdollahi, Mohammad M, Mojahed, Fresia F, Alizadehgan, Ahlam Madani AM and Dehghan, Gholamreza G.. (2009) Acetylcholinesterase/butyrylcholinesterase inhibition activity of some new carbacylamidophosphate derivatives.. Journal of enzyme inhibition and medicinal chemistry, [PMID:18825527] |
| 197. Naik, Runa S RS and 5 more authors.. (2009) Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice.. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, [PMID:19470293] |
| 198. Ki, Yo Sook YS and 7 more authors.. (2010) Donepezil, a potent acetylcholinesterase inhibitor, induces caspase-dependent apoptosis in human promyelocytic leukemia HL-60 cells.. Biological & pharmaceutical bulletin, [PMID:20522977] |
| 199. Raza, Rabia R and 6 more authors.. (2012) Synthesis and biological evaluation of 3-thiazolocoumarinyl Schiff-base derivatives as cholinesterase inhibitors.. Chemical biology & drug design, [PMID:22726458] |
| 200. Macdonald, Ian R IR, Martin, Earl E, Rosenberry, Terrone L TL and Darvesh, Sultan S.. (2012) Probing the peripheral site of human butyrylcholinesterase.. Biochemistry, (11): [PMID:22901043] |
| 201. Kanhed, Ashish M AM and 7 more authors.. (2015) Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesis.. Bioorganic chemistry, [PMID:26042530] |
| 202. Osman, Wesseem W and 5 more authors.. (2016) Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.. Chemical biology & drug design, [PMID:27282589] |
